New approach methods to assess developmental and adult neurotoxicity for regulatory use: a PARC work package 5 project

Archive ouverte

Tal, Tamara | Myhre, Oddvar | Fritsche, Ellen | Rüegg, Joëlle | Craenen, Kai | Aiello-Holden, Kiara | Agrillo, Caroline | Babin, Patrick J. | Escher, Beate, I | Dirven, Hubert | Hellsten, Kati | Dolva, Kristine | Hessel, Ellen | Heusinkveld, Harm, J. | Hadzhiev, Yavor | Hurem, Selma | Jagiello, Karolina | Judzinska, Beata | Klüver, Nils | Knoll-Gellida, Anja | Kühne, Britta A | Leist, Marcel | Lislien, Malene | Lyche, Jan L | Müller, Ferenc | Colbourne, John K. | Neuhaus, Winfried | Pallocca, Giorgia | Seeger, Bettina | Scharkin, Ilka | Scholz, Stefan | Spjuth, Ola | Torres-Ruiz, Mónica | Bartmann, Kristina

Edité par CCSD ; Frontiers Media -

International audience. In the European regulatory context, rodent studies are the predominant source of neurotoxicity information. Although they form a cornerstone of neurotoxicological assessments, they are costly and the topic of ethical debate. While the public expects chemicals and products to be safe for the developing and mature nervous systems, considerable numbers of chemicals in commerce have not, or only to a limited extent, been assessed for their potential to cause neurotoxicity. As such, there is a societal push toward the replacement of animal models with or alternative methods. New approach methods (NAMs) can contribute to the regulatory knowledge base, increase chemical safety, and modernize chemical hazard and risk assessment. Provided they reach an acceptable level of regulatory relevance and reliability, NAMs may be considered as replacements for specific studies. The European Partnership for the Assessment of Risks from Chemicals (PARC) addresses challenges to the development and implementation of NAMs in chemical risk assessment. In collaboration with regulatory agencies, Project 5.2.1e (Neurotoxicity) aims to develop and evaluate NAMs for developmental neurotoxicity (DNT) and adult neurotoxicity (ANT) and to understand the applicability domain of specific NAMs for the detection of endocrine disruption and epigenetic perturbation. To speed up assay time and reduce costs, we identify early indicators of later-onset effects. Ultimately, we will assemble second-generation developmental neurotoxicity and first-generation adult neurotoxicity test batteries, both of which aim to provide regulatory hazard and risk assessors and industry stakeholders with robust, speedy, lower-cost, and informative next-generation hazard and risk assessment tools.

Suggestions

Du même auteur

A critical review to identify data gaps and improve risk assessment of bisphenol A alternatives for human health

Archive ouverte | Mhaouty-Kodja, Sakina | CCSD

International audience. Bisphenol A (BPA), a synthetic chemical widely used in the production of polycarbonate plastic and epoxy resins, has been associated with a variety of adverse effects in humans including meta...

Innovative tools and methods for toxicity testing within PARC work package 5 on hazard assessment

Archive ouverte | de Castelbajac, Thalia | CCSD

International audience. New approach methodologies (NAMs) have the potential to become a major component of regulatory risk assessment, however, their actual implementation is challenging. The European Partnership f...

The ENDpoiNTs Project: Novel Testing Strategies for Endocrine Disruptors Linked to Developmental Neurotoxicity

Archive ouverte | Lupu, Diana | CCSD

International audience. Ubiquitous exposure to endocrine-disrupting chemicals (EDCs) has caused serious concerns about the ability of these chemicals to affect neurodevelopment, among others. Since endocrine disrupt...

Chargement des enrichissements...